Chlordiazepoxide/Clidinium Capsule
Chlordiazepoxide/clidinium is used to treat irritable bowel syndrome (IBS) in dogs. The medication combines a benzodiazepine (chlordiazepoxide) for anxiety with an anticholinergic/antispasmodic (clidinium) to relax the gut.
Use as directed by your veterinarian.
This compounded formulation combines chlordiazepoxide, a benzodiazepine, with clidinium, an anticholinergic — two different drug classes. In compounding practice, clinicians may consider a combination like this for a multi-targeted approach. Your veterinarian determines whether it is appropriate based on your animal's diagnostic findings.
At a pharmacological level, this medication functions through complementary mechanisms. Chlordiazepoxide acts by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system. This enhancement manages the excitability of neurons, providing a mechanism for addressing anxiety and managing the stress signals that often precede gut motility issues. Clidinium bromide acts as a competitive antagonist at muscarinic acetylcholine receptors located on the smooth muscles of the digestive tract. This process help address the excessive cholinergic stimulation that leads to intestinal cramping and hypermotility. Together, these ingredients manage the involuntary spasms and emotional reactivity associated with various digestive concerns. Your veterinarian will determine the clinical appropriateness of this combination based on your pet’s physical signs and behavioral history.
This description reflects the general pharmacology of the active ingredient's drug class; your veterinarian determines whether this approach is appropriate for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of chlordiazepoxide/clidinium include mild sedation, temporary coordination shifts (ataxia) or a dry mouth (xerostomia). Because of the anticholinergic component, some pets may exhibit localized changes such as decreased tear production or a slight increase in heart rate. Owners should watch for behavioral shifts including lethargy or unusual restlessness and contact their veterinarian promptly with any concerns.
This medication is typically used with extra caution or avoided in patients with known the relevant ophthalmic condition, as anticholinergics can influence intraocular pressure. It is also carefully evaluated in pets presented with prostatic hypertrophy, urinary obstruction or severe hepatic impairment. Significant interactions can occur if this combination is administered concurrently with other central nervous system depressants or specific prescriptions that share anticholinergic properties. Long-term use requires careful clinical oversight, and your veterinarian is the right person to provide guidance on the necessary duration of use and the most commonly considered tapering schedule to ensure the management approach remains suitable for your pet’s individual health status.
Yes. Chlordiazepoxide/clidinium is a combination of prescription medications and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all veterinarian-client-patient relationships before any medication is prepared or shipped to your home.
Yes. While this combination is available in commercial capsules intended for human use, Mixlab specializes in compounding the active ingredients into customized strengths and flavored dosage forms—such as flavored oral liquids or smaller capsules—to suit the specific weight and needs of dogs and cats. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss this combination because the gut and the brain are closely linked. Stress and anxiety can trigger physical spasms and discomfort in the digestive tract, so by managing the pet's stress levels while simultaneously relaxing the gut muscles, the medication addresses both the cause and the symptoms of the condition.
The most important observational signs to watch for include excessive sleepiness, stumbling while walking or a noticeable decrease in appetite. You should also monitor for signs of constipation or difficulty urinating and contact your veterinarian immediately if you observe any of these changes after starting the medication.
